Tue, Jul 29, 2014, 2:07 AM EDT - U.S. Markets open in 7 hrs 23 mins

Recent

% | $
Click the to save as a favorite.

Insmed Incorporated Message Board

  • fudfighter3 fudfighter3 Mar 27, 2014 10:36 AM Flag

    Who were the real victims of yesterday's scam?

     

    For the sake of argument let's assume that yesterday's selling was NOT (perish the thought) partly comprised of sales by investors who had the benefit of a private guarantee from the Insmed BOD that if they sold on the news, the BOD would line their pockets at our expense via a share offering at a lower price.

    The Nasdaq site shows the total volume of shares traded yesterday as just over 7.8 million shares.

    As usual I'd welcome input, but my personal gut feeling is that the majority of those trades (5 million?) would have been by professional investors selling and subsequently buying back.

    Another chunk (0.8 million?) would have been by momentum traders interested only in the anticipated rise on the news, who will have sold and won't look back.

    The remaining 2 million (perhaps a lot more?) represent money in the bank for us - shareholders who sold because of the drop, but know the stock quite well and will buy back their shares for much the same reasons as they bought them in the first place.

    And what of the Short position - 3 million shares as of mid-March?

    I wouldn't be surprised if investors with Short positions bought back a million shares yesterday.

    But that would still leave a total unsatisfied demand of 4 million shares (going by the figures I've suggested).

    And the problem those investors now face is that yesterday's drop was little more than a trading scam. The Nasdaq site displayed a prominent article heading along the lines of -

    INSMED'S DRUG FAILS IN EARLY-STAGE CLINICAL TRIAL

    However I'm pretty sure that very few shares now are not in the hands of investors who understand Arikace is all but guaranteed after yesterday's news to be approved both for Cystic Fibrosis and for NTM on the basis of the data already in the bag.

    We'll still see a high volume of trades by investors trading in and out. But if not the Insmed BOD - who is now going to part with four million shares at anywhere near the current price?

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
17.10-0.40(-2.29%)Jul 28 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.